+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Generic Pharmaceuticals Global Market Report 2022: By Therapy, By Distribution, By Type, By Drug

  • PDF Icon

    Report

  • 400 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5553736
Generic Pharmaceuticals Global Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market.



The report focuses on the generic pharmaceuticals market which is experiencing strong growth. The report gives a guide to the generic pharmaceuticals market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the generic pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Generic Pharmaceuticals Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers

Scope


Markets Covered:


1) By Therapy: CNS; Cardiovascular; Dermatology; Genitourinary/Harmonal; Respiratory; Rheumatology; Diabetes; Oncology
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Type: Biosimilar; Simple Generic; Super Generic
4) By Drug Delivery: Oral; Inectables; Dermal/Topical; Inhaler

Companies Mentioned: Teva Pharmaceuticals; Mylan NV; Sandoz International GmbH; Hospira (Pfizer Inc); Sun Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Frequently Asked Questions about the Global Generic Pharmaceuticals Market

What is the estimated value of the Global Generic Pharmaceuticals Market?

The Global Generic Pharmaceuticals Market was estimated to be valued at $332.43 billion in 2022.

What is the growth rate of the Global Generic Pharmaceuticals Market?

The growth rate of the Global Generic Pharmaceuticals Market is 6.4%, with an estimated value of $426.3 billion by 2026.

What is the forecasted size of the Global Generic Pharmaceuticals Market?

The Global Generic Pharmaceuticals Market is estimated to be worth $426.3 billion by 2026.

Who are the key companies in the Global Generic Pharmaceuticals Market?

Key companies in the Global Generic Pharmaceuticals Market include Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer inc.), Sun Pharmaceutical, Lupin Limited, Endo International plc., Dr Reddy's Laboratories and Fresenius Kabi Ag.

Table of Contents

1. Executive Summary2. Generic Pharmaceuticals Market Characteristics3. Generic Pharmaceuticals Market Trends And Strategies4. Impact Of COVID-19 On Generic Pharmaceuticals
5. Generic Pharmaceuticals Market Size And Growth
5.1. Global Generic Pharmaceuticals Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Generic Pharmaceuticals Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Generic Pharmaceuticals Market Segmentation
6.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Harmonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
6.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
6.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Biosimilar
  • Simple Generic
  • Super Generic
6.4. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Inectables
  • Dermal/Topical
  • Inhaler

7. Generic Pharmaceuticals Market Regional And Country Analysis
7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Generic Pharmaceuticals Market
8.1. Asia-Pacific Generic Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Generic Pharmaceuticals Market
9.1. China Generic Pharmaceuticals Market Overview
9.2. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Generic Pharmaceuticals Market
10.1. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Generic Pharmaceuticals Market
11.1. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Generic Pharmaceuticals Market
12.1. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Generic Pharmaceuticals Market
13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Generic Pharmaceuticals Market
14.1. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Generic Pharmaceuticals Market
15.1. Western Europe Generic Pharmaceuticals Market Overview
15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Generic Pharmaceuticals Market
16.1. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Generic Pharmaceuticals Market
17.1. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Generic Pharmaceuticals Market
18.4. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Generic Pharmaceuticals Market
19.1. Eastern Europe Generic Pharmaceuticals Market Overview
19.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Generic Pharmaceuticals Market
20.1. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Generic Pharmaceuticals Market
21.1. North America Generic Pharmaceuticals Market Overview
21.2. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Generic Pharmaceuticals Market
22.1. USA Generic Pharmaceuticals Market Overview
22.2. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Generic Pharmaceuticals Market
23.1. South America Generic Pharmaceuticals Market Overview
23.2. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Generic Pharmaceuticals Market
24.1. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Generic Pharmaceuticals Market
25.1. Middle East Generic Pharmaceuticals Market Overview
25.2. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Generic Pharmaceuticals Market
26.1. Africa Generic Pharmaceuticals Market Overview
26.2. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles
27.1. Generic Pharmaceuticals Market Competitive Landscape
27.2. Generic Pharmaceuticals Market Company Profiles
27.2.1. Teva Pharmaceuticals
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Mylan NV
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Sandoz International GmbH
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Hospira (Pfizer Inc.)
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Sun Pharmaceutical
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Generic Pharmaceuticals Pipeline Analysis29. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market30. Generic Pharmaceuticals Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer

Executive Summary

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical, Lupin Limited, Endo International Plc., Dr Reddy's Laboratories, Apotex Holdings, Fresenius Kabi Ag, Aurbindo Pharma, Aspen Pharmacare, Sanofi, Cipla, Hikma Pharmaceuticals, Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Merck & Co., Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Nexus Pharmaceuticals, Novo Nordisk, Ranbaxy Laboratories Ltd., Sawai Pharmaceuticals, Novartis AG, Pfizer and Johnson & Johnson Services.

The global generic pharmaceuticals market is expected to grow from $302.39 billion in 2021 to $332.43 billion in 2022 at a compound annual growth rate (CAGR) of 9.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $426.30 billion in 2026 at a CAGR of 6.4%.

The generic pharmaceuticals market consists of sales of generic pharmaceuticals. A generic medicine is a medication designed to be identical as branded drugs marketed by private companies in dosage form, strength, safety, route of administration, performance characteristics, quality, and intended use. Generic drugs work in the same way as branded drugs in terms of clinical benefits. Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs. For example, some of the generic drugs in the generic pharmaceuticals market include metformin, metoprolol, acarbose, acebutolol, aztreonam and many more.

The main types of generic pharmaceuticals are biosimilar; simple generic and super generic. A biosimilar is a biological product that is very similar to a reference biologic and has no clinically significant differences in terms of safety, purity, or potency. The drugs are delivered through oral, injectables, dermal/topical and inhaler that are used for various therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes and oncology. The various distribution channel involved are hospital pharmacies, retail pharmacies and online pharmacies.

North America was the largest region in the generic pharmaceuticals market in 2021. Middle East is expected to be the largest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for the treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost having the same chemical composition of branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes for a longer period of time and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, the deaths due to chronic disease is projected to increase by 17%. Also, in 2020, almost 3-quarters of all deaths in the world is due to chronic diseases.

The lack of awareness about generic drugs is one of the restraints on the generic pharmaceuticals market. The high marketing and advertisement of branded drugs overshadow the availability of generic drugs which are substitute for expensive branded drugs. Thus, consumers opt branded drugs despite the fact that the generic drugs carry the same chemical formulation as their counter branded drugs. According to an article published on CVS HEALTH, many doctors and pharmacists preferred to offer branded drugs to their patients over generic drugs. This prevents the patients to go for generic drugs as they develop a preconceived notion of generic drugs not being at par with branded drugs. For example, according to a research conducted by Sahana K Hebbar, on International Journal of Basic & Clinical Pharmacology, out of 100 patients and 50 non-medical staff, 95% of the patients and 60% of the non-medical staff didn't know about generic drugs. Thus, lack of awareness about the availability of generic drugs hamper the generic pharmaceuticals market.

3D printing technology has the ability to transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals help in improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances and taste. For example, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing advantages to manufacture pills and tablets. Also, Aprecia pharmaceutical company launched 'ZipDose' technology which manufactures 3D printed drugs.

The drug manufacturers must comply with the CGMP (Current Good Manufacturing Practice) regulations that come under the US Food and Drug Administration (FDA) which includes generic pharmaceuticals. The CGMP regulations require manufacturers to maintain a minimum quality standard for the methods, controls, and facilities used in manufacturing, packaging, and processing of drug product. The part- 99 of chapter 1 under title 21-Food And Drugs of CFR (Code of Federal Regulations) contains subparts from A to H. The whole part-99 describes the guidelines that need to be followed by drug manufacturers regarding the dissemination of information on human drugs, including biologics, and devices. The guidelines concern with the safety, effectiveness, or benefit of use that is not included in the approved labelling for a drug or device approved by the Food and Drug Administration for marketing. The guidelines regulate the information regarding the drugs that should be delivered to the health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency.

In January 2020, ANI Pharmaceuticals, Inc., a USA based integrated specialty pharmaceutical company focused on developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals acquired Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. for $52.5M in cash. This acquisition substantially increases ANI Pharmaceuticals, Inc. commercial portfolio and late stage generic pipeline. Amerigen Pharmaceuticals, a USA based company focused on development, manufacture and sale of high quality generic pharmaceutical products.

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Teva Pharmaceuticals
  • Mylan NV
  • Sandoz International GmbH
  • Hospira (Pfizer inc.)
  • Sun Pharmaceutical
  • Lupin Limited
  • Endo International plc.
  • Dr Reddy's Laboratories
  • Apotex Holdings
  • Fresenius Kabi Ag
  • Aurbindo Pharma
  • Aspen Pharmacare
  • Sanofi
  • Cipla
  • Hikma Pharmaceuticals
  • Stada Arzneimittel
  • Krka Group
  • Nichi-Iko Pharmaceutical
  • Valeant
  • Zydus Cadila
  • Merck & Co.
  • Mitsubishi Tanabe Pharma
  • Momenta Pharmaceuticals
  • Nexus Pharmaceuticals
  • Novo Nordisk
  • Ranbaxy Laboratories Ltd.
  • Sawai Pharmaceuticals
  • Novartis AG
  • Pfizer
  • Johnson & Johnson Services

Methodology

Loading
LOADING...